IN2008MU02299A - - Google Patents

Download PDF

Info

Publication number
IN2008MU02299A
IN2008MU02299A IN2299MU2008A IN2008MU02299A IN 2008MU02299 A IN2008MU02299 A IN 2008MU02299A IN 2299MU2008 A IN2299MU2008 A IN 2299MU2008A IN 2008MU02299 A IN2008MU02299 A IN 2008MU02299A
Authority
IN
India
Application number
Inventor
Dewan Mohan
Original Assignee
Dewan Mohan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dewan Mohan filed Critical Dewan Mohan
Priority to IN2299MU2008 priority Critical patent/IN2008MU02299A/en
Publication of IN2008MU02299A publication Critical patent/IN2008MU02299A/en

Links

IN2299MU2008 2008-10-24 2008-10-24 IN2008MU02299A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2299MU2008 IN2008MU02299A (en) 2008-10-24 2008-10-24

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2299MU2008 IN2008MU02299A (en) 2008-10-24 2008-10-24

Publications (1)

Publication Number Publication Date
IN2008MU02299A true IN2008MU02299A (en) 2010-08-06

Family

ID=82701996

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2299MU2008 IN2008MU02299A (en) 2008-10-24 2008-10-24

Country Status (1)

Country Link
IN (1) IN2008MU02299A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017020125A1 (en) * 2015-07-31 2017-02-09 Delivra Inc. Transdermal formulations for delivery of capsaicinoids
WO2022155352A1 (en) * 2021-01-13 2022-07-21 Dyve Biosciences, Inc. Transdermal penetrant formulations for administration of medicaments
WO2022155341A1 (en) * 2021-01-13 2022-07-21 Dyve Biosciences, Inc. Transdermal formulations for phosphodiesterase-5 inhibitors

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017020125A1 (en) * 2015-07-31 2017-02-09 Delivra Inc. Transdermal formulations for delivery of capsaicinoids
US10898537B2 (en) 2015-07-31 2021-01-26 Delivra Inc. Transdermal formulations for delivery of capsaicinoids
WO2022155352A1 (en) * 2021-01-13 2022-07-21 Dyve Biosciences, Inc. Transdermal penetrant formulations for administration of medicaments
WO2022155341A1 (en) * 2021-01-13 2022-07-21 Dyve Biosciences, Inc. Transdermal formulations for phosphodiesterase-5 inhibitors
CN115379837A (en) * 2021-01-13 2022-11-22 黛芙生物科学公司 Transdermal formulations for drug administration

Similar Documents

Publication Publication Date Title
BRPI0909040A2 (en)
BRPI0917573A2 (en)
BRPI0908549B8 (en)
BRPI0918697A2 (en)
BRPI0917525A2 (en)
BRPI0920750A2 (en)
BRPI0919470A2 (en)
BRPI0922455A2 (en)
BRPI0917618A8 (en)
BRPI0907698A2 (en)
BRPI0912727A2 (en)
BRPI0923734A2 (en)
BRPI0908285A2 (en)
BRPI0910485A2 (en)
BRPI0914750A2 (en)
BRPI0908120A2 (en)
BRPI0922669A2 (en)
BRPI0912462A2 (en)
BRPI0915616A2 (en)
BRPI0919811A2 (en)
BRPI0920914A2 (en)
BRPI0916284A2 (en)
BRPI0922550A2 (en)
BRPI0909508A2 (en)
BRPI0913605A2 (en)